grapiprant (Galliprant)

Indications: - treatment of osteoarthritis in dogs Dosage: - tablets 20 mg Mechanism of action: - PGE2 receptor antagonist

Interactions

drug adverse effects of NSAIDs monitor with non steroidal anti-inflammatory agents (NSIADs)

References

FDA Animal & Veterinary. March 21, 2016 FDA Approves Galliprant, a New Animal Drug for Osteoarthritis in Dogs. http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm491552.htm